Hengrui Is Supplying Big Pharma’s Pipeline. Now It Wants the Upside Too.
With $139.4 billion in Chinese drug licensing deals this year, the question for healthcare investors is who actually owns the…
With $139.4 billion in Chinese drug licensing deals this year, the question for healthcare investors is who actually owns the…
October 15, 2026 Bonus Content: When a Grid Spike Ruins a Glucose Sensor, Flywheels Win...
Dow reports Oct. 22. The key question is whether stover supply is real.
Seoul’s circuit breakers and Tokyo’s 4.9% drop hand the US open a pre-damaged chip sector. Here is where the risk…
October 15, 2026 Bonus Content: Africa’s Phone King Is Listing in Hong Kong at a...
Greenland Mines (GRML) has real assets on the island, but dilution, cash burn, and Greenland's own regulatory walls make the…
Healey’s Oct. 28 Budget plan shifts VAT to marketplaces
October 13, 2026 Bonus Content: BrainChip Has Defense Contracts. Its Cash Runs Out in Four...
Water utilities still run exposed controllers and old firmware
The $2.4 billion headline obscures a wide gap between firms with large commitments and those offering modest credits.